Literature DB >> 15677712

The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.

Noritada Yoshikawa1, Keiko Yamamoto, Noriaki Shimizu, Sachiko Yamada, Chikao Morimoto, Hirotoshi Tanaka.   

Abstract

Recent structural analyses of the nuclear receptors establish a paradigm of receptor activation, in which agonist binding induces the ligand binding domain (LBD)/activation function-2 helix to form a charge clamp for coactivator recruitment. However, these analyses have not sufficiently addressed the mechanisms for differential actions of various synthetic steroids in terms of fine tuning of multiple functions of whole receptor molecules. In the present study, we used the glucocorticoid receptor (GR)-specific agonist cortivazol (CVZ) to probe the plasticity and functional modularity of the GR. Structural docking analysis revealed that although CVZ is more bulky than other agonists, it can be accommodated in the ligand binding pocket of the GR by reorientation of several amino acid side chains but without major alterations in the active conformation of the LBD. In this induced fit model, the phenylpyrazole A-ring of CVZ establishes additional contacts with helices 3 and 5 of the LBD that may contribute to a more stable LBD configuration. Structural and functional analysis revealed that CVZ is able to compensate for the deleterious effects of a C-terminal deletion of the LBD in a manner that mimics the stabilizing influence of the F602S point mutation. CVZ-mediated productive recruitment of transcriptional intermediary factor 2 to the C-terminally deleted LBD requires the receptor's own DNA binding domain and is positively influenced by the N-terminal regions of GR or progesterone receptor. These results support a model where ligand-dependent conformational changes in the LBD play a role in GR-mediated gene regulation via modular interaction with the DBD and activation function-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15677712     DOI: 10.1210/me.2004-0264

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  6 in total

1.  Tissue- and context-dependent modulation of hormonal sensitivity of glucocorticoid-responsive genes by hexamethylene bisacetamide-inducible protein 1.

Authors:  Noriaki Shimizu; Noritada Yoshikawa; Tadashi Wada; Hiroshi Handa; Motoaki Sano; Keiichi Fukuda; Makoto Suematsu; Takashi Sawai; Chikao Morimoto; Hirotoshi Tanaka
Journal:  Mol Endocrinol       Date:  2008-09-18

2.  Determinants of the heightened activity of glucocorticoid receptor translational isoforms.

Authors:  Ingrid K Bender; Yun Cao; Nick Z Lu
Journal:  Mol Endocrinol       Date:  2013-07-02

3.  HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.

Authors:  Noriaki Shimizu; Rika Ouchida; Noritada Yoshikawa; Tetsuya Hisada; Hajime Watanabe; Kensaku Okamoto; Masatoshi Kusuhara; Hiroshi Handa; Chikao Morimoto; Hirotoshi Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-07       Impact factor: 11.205

4.  Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis.

Authors:  Satori Tokudome; Motoaki Sano; Ken Shinmura; Tomohiro Matsuhashi; Shintaro Morizane; Hidenori Moriyama; Kayoko Tamaki; Kentaro Hayashida; Hiroki Nakanishi; Noritada Yoshikawa; Noriaki Shimizu; Jin Endo; Takaharu Katayama; Mitsushige Murata; Shinsuke Yuasa; Ruri Kaneda; Kengo Tomita; Naomi Eguchi; Yoshihiro Urade; Koichiro Asano; Yasunori Utsunomiya; Takeshi Suzuki; Ryo Taguchi; Hirotoshi Tanaka; Keiichi Fukuda
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

5.  Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor.

Authors:  Keith Biggadike; Randy K Bledsoe; Diane M Coe; Tony W J Cooper; David House; Marie A Iannone; Simon J F Macdonald; Kevin P Madauss; Iain M McLay; Tracy J Shipley; Simon J Taylor; Thuy B Tran; Iain J Uings; Victoria Weller; Shawn P Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

6.  A screening assay for Selective Dimerizing Glucocorticoid Receptor Agonists and Modulators (SEDIGRAM) that are effective against acute inflammation.

Authors:  Jolien Souffriau; Melanie Eggermont; Sara Van Ryckeghem; Kelly Van Looveren; Lise Van Wyngene; Evelien Van Hamme; Marnik Vuylsteke; Rudi Beyaert; Karolien De Bosscher; Claude Libert
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.